12-67649940-C-T

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_006482.3(DYRK2):​c.193C>T​(p.His65Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.000172 in 1,373,948 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00017 ( 0 hom. )

Consequence

DYRK2
NM_006482.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.88
Variant links:
Genes affected
DYRK2 (HGNC:3093): (dual specificity tyrosine phosphorylation regulated kinase 2) DYRK2 belongs to a family of protein kinases whose members are presumed to be involved in cellular growth and/or development. The family is defined by structural similarity of their kinase domains and their capability to autophosphorylate on tyrosine residues. DYRK2 has demonstrated tyrosine autophosphorylation and catalyzed phosphorylation of histones H3 and H2B in vitro. Two isoforms of DYRK2 have been isolated. The predominant isoform, isoform 1, lacks a 5' terminal insert. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021955192).
BS2
High AC in GnomAd4 at 30 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DYRK2NM_006482.3 linkuse as main transcriptc.193C>T p.His65Tyr missense_variant 2/3 ENST00000344096.4 NP_006473.2 Q92630-1
DYRK2XM_017020032.2 linkuse as main transcriptc.-876C>T 5_prime_UTR_variant 1/2 XP_016875521.1 Q92630-2
DYRK2NM_003583.4 linkuse as main transcriptc.-22+758C>T intron_variant NP_003574.1 Q92630-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DYRK2ENST00000344096.4 linkuse as main transcriptc.193C>T p.His65Tyr missense_variant 2/31 NM_006482.3 ENSP00000342105.4 Q92630-1

Frequencies

GnomAD3 genomes
AF:
0.000198
AC:
30
AN:
151828
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000943
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000242
AC:
9
AN:
37186
Hom.:
0
AF XY:
0.000131
AC XY:
3
AN XY:
22952
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000821
Gnomad NFE exome
AF:
0.000317
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000169
AC:
207
AN:
1222010
Hom.:
0
Cov.:
30
AF XY:
0.000186
AC XY:
111
AN XY:
595666
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000407
Gnomad4 NFE exome
AF:
0.000187
Gnomad4 OTH exome
AF:
0.000120
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
151938
Hom.:
0
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74284
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000943
Gnomad4 NFE
AF:
0.000177
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000215
ExAC
AF:
0.0000894
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMar 01, 2023The c.193C>T (p.H65Y) alteration is located in exon 2 (coding exon 2) of the DYRK2 gene. This alteration results from a C to T substitution at nucleotide position 193, causing the histidine (H) at amino acid position 65 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.33
CADD
Benign
23
DANN
Benign
0.96
DEOGEN2
Benign
0.21
T
Eigen
Benign
-0.22
Eigen_PC
Benign
-0.042
FATHMM_MKL
Benign
0.53
D
LIST_S2
Benign
0.58
T
M_CAP
Benign
0.047
D
MetaRNN
Benign
0.022
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Uncertain
2.1
M
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-1.1
N
REVEL
Benign
0.085
Sift
Benign
0.56
T
Sift4G
Benign
1.0
T
Polyphen
0.022
B
Vest4
0.34
MutPred
0.38
Gain of catalytic residue at I67 (P = 0.0013);
MVP
0.57
MPC
0.65
ClinPred
0.095
T
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.16
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs557502236; hg19: chr12-68043720; API